Prev Arrow Stocks

UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 5.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is UnitedHealth Group Incorporated (DE)?

UnitedHealth Group (UNH) is a diversified health and well-being company that aims to promote healthier lives. The market sentiment for UNH today leaned towards a bearish outlook.

Why is UnitedHealth Group Incorporated (DE) going down?

UNH stock is down 5.1% on Jan 16, 2025 18:20

  • UNH reported Q4 earnings surpassing adjusted EPS projections but falling short on revenue, resulting in a bearish movement in the stock.
  • Concerns about potential impacts on peers, such as Humana (HUM), following UNH's earnings report contributed to the downward trend in UNH shares.
  • The government's payment rate affecting insurers' pricing and profitability added to market unease regarding the sector.
  • Despite outperforming earnings estimates, a slight revenue miss and the prevailing market sentiment led to a bearish day for UnitedHealth Group's stock.

UNH Price Chart

UNH Technical Analysis

UNH News

What's Going On With Humana Stock? - Humana ( NYSE:HUM )

Humana shares are trading lower by 3.0% during Thursday's session. Shares are lower following UnitedHealth Group's earnings report, reflecting concerns about potential impacts on peers. Get 5 New Stock Recommendations Every Week

https://www.benzinga.com/news/25/01/43036800/whats-going-on-with-humana-stock

0 News Article Image What's Going On With Humana Stock? - Humana  ( NYSE:HUM )

UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls - UnitedHealth Group ( NYSE:UNH )

UnitedHealth's Q4 adjusted EPS of $6.81 beat consensus of $6.72, while revenue hit $100.8 billion, missing estimates of $101.8 billion 2025 guidance reaffirms sales of $450 billion-$455 billion and adjusted EPS of $29.50-$30.00. Get Real-Time News and Alerts for Your Portfolio

https://www.benzinga.com/general/health-care/25/01/43025159/unitedhealth-q4-earnings-revenue-falls-short-medical-ratio-rises-to-85-5-stock-falls

1 News Article Image UnitedHealth Q4 Earnings: Revenue Falls Short, Medical Ratio Rises To 85.5%, Stock Falls - UnitedHealth Group  ( NYSE:UNH )

Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?

The government's payment rate directly impacts insurers' pricing, plan benefits and overall profitability.

https://www.zacks.com/stock/news/2397958/will-unh-hum-cvs-be-the-top-beneficiaries-of-the-21b-ma-boom

2 Missing News Article Image Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?

UnitedHealth Group ( UNH ) Beats Q4 Earnings Estimates

UnitedHealth (UNH) delivered earnings and revenue surprises of 1.49% and 1.41%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2397946/unitedhealth-group-unh-beats-q4-earnings-estimates

3 Missing News Article Image UnitedHealth Group  ( UNH )  Beats Q4 Earnings Estimates

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Thursday - Bank of America ( NYSE:BAC ) , Morgan Stanley ( NYSE:MS )

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Bank of America Corp. BAC to report quarterly earnings at 77 cents per share on revenue of $25.19 billion before the opening bell, according ...

https://www.benzinga.com/25/01/43021568/bank-of-america-morgan-stanley-and-3-stocks-to-watch-heading-into-thursday

4 News Article Image Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Thursday - Bank of America  ( NYSE:BAC ) , Morgan Stanley  ( NYSE:MS )

UnitedHealth Group Incorporated (DE) Price History

06.11.2024 - UNH Stock was down 5.3%

  • The tragic death of UnitedHealthcare's CEO, Brian Thompson, has led to increased scrutiny and industry criticism, impacting the company's stock price negatively.
  • The mysterious messages found on the bullets used in the shooting, such as "deny," "depose," and "defend," have raised concerns and speculation about a potential motive behind the attack, adding further uncertainty for investors.
  • The release of photos of a person wanted for questioning in connection with the CEO's shooting has added to the ongoing investigation and created additional unease among shareholders.
  • The clouded outlook for UnitedHealth's 2025 operating cash flows, coupled with the loss of a key leader, has likely contributed to the bearish market movement of UNH stock as investors weigh the potential impact of these events on the company's future performance.

15.09.2024 - UNH Stock was down 7.1%

  • UNH reported better-than-expected third-quarter earnings but revised its annual EPS outlook lower, leading to a bearish market reaction.
  • The company's adjustment in annual profit guidance was influenced by a cyberattack on Change Healthcare, impacting investor sentiment.
  • Despite beating revenue and EPS estimates, the market focused on the revised outlook, causing a negative impact on UNH stock.

11.11.2024 - UNH Stock was down 5.0%

  • UNH faced significant bearish movement today, reflecting wider declines in health care stocks.
  • The market's negative response may be linked to proposed bipartisan legislation targeting pharmacy benefit managers, affecting UNH's business operations.
  • The recent unfortunate event involving the murder of UnitedHealthcare CEO Brian Thompson by a person of interest possibly added uncertainty and pressure on the company's stock.
  • The overall struggling performance of health insurers, including UNH, due to increasing costs, denied claims, and industry hurdles has also contributed to the stock's bearish trend.

15.09.2024 - UNH Stock was down 8.6%

  • UnitedHealth Group reported better-than-expected third-quarter earnings but revised its annual profit guidance lower due to the impact of a cyberattack on Change Healthcare.
  • Despite beating revenue and EPS estimates, the company's decision to lower the upper end of its annual EPS outlook contributed to the bearish sentiment.
  • The short interest in UnitedHealth Group has fallen, indicating a potential shift in market sentiment towards the stock.
  • The overall market sentiment towards UnitedHealth Group was overshadowed by concerns about the cyberattack impact and the revised profit guidance, leading to the bearish movement in the stock.

15.09.2024 - UNH Stock was down 8.2%

  • UNH reported better-than-expected third-quarter earnings, driven by client wins in the Optum Rx sub-unit. However, challenges such as elevated operating expenses and a cyberattack on Change Healthcare affected its annual profit guidance.
  • The stock's bearish movement followed UNH revising the upper end of its annual EPS outlook lower, which led to a negative sentiment among investors.
  • Furthermore, sympathy trading with other health insurers like CVS Health, which also saw a decline in stock price, may have contributed to the downward pressure on UNH shares.
  • Despite positive earnings and revenue surprises, the market may be taking a cautious stance on UNH's future prospects, awaiting more clarity on the company's plans to address challenges and sustain growth.

16.00.2025 - UNH Stock was down 5.1%

  • UNH reported Q4 earnings surpassing adjusted EPS projections but falling short on revenue, resulting in a bearish movement in the stock.
  • Concerns about potential impacts on peers, such as Humana (HUM), following UNH's earnings report contributed to the downward trend in UNH shares.
  • The government's payment rate affecting insurers' pricing and profitability added to market unease regarding the sector.
  • Despite outperforming earnings estimates, a slight revenue miss and the prevailing market sentiment led to a bearish day for UnitedHealth Group's stock.

06.10.2024 - UNH Stock was up 7.1%

  • The bullish movement in UNH stock today can be attributed to the positive long-term performance, instilling confidence in investors.
  • The bearish options market dynamics may have been overshadowed by the positive sentiment surrounding UNH's historical returns and market capitalization.
  • The upcoming inclusion of Nvidia in the Dow Jones Industrial Average could have also contributed to the overall bullish market sentiment, indirectly benefiting UNH as part of the broader market rally.
  • Despite the competitive landscape, UNH's strong financial position and track record seem to have positioned it favorably in today's trading session.

05.11.2024 - UNH Stock was down 5.1%

  • The bearish movement in UnitedHealth Group's stock (UNH) today can be attributed to the tragic incident involving the fatal shooting of CEO Brian Thompson. The market reaction can be summarized as follows:
  • The news of the CEO's untimely death and the mysterious circumstances surrounding the shooting likely led to investor uncertainty and a loss of confidence in the company's leadership.
  • The release of photos of a person wanted for questioning in connection with the shooting added to the speculation and negative sentiment surrounding the stock.
  • The company's 2025 outlook being clouded by the loss of a key leader may have also contributed to the downward pressure on the stock price.
  • Overall, the combination of the shocking event, the uncertainty regarding the motive behind the shooting, and the potential implications for UnitedHealth Group's future direction all played a role in the bearish market movement of UNH shares today.

17.11.2024 - UNH Stock was down 5.4%

  • UNH stock saw a significant decline in value today.
  • Concerns arose after President-elect Donald Trump revealed plans to target Pharmacy-benefit managers (PBMs), impacting UNH negatively.
  • The unfortunate event involving the death of UNH CEO Brian Thompson likely contributed to the company's negative perception.
  • Despite the bearish trend, some well-funded investors have taken a bullish stance on UNH in the options market, hinting at potential optimism for the stock's performance in the future.

16.06.2024 - UNH Stock was up 5.7%

  • UNH demonstrated significant bullish movement today, with its stock price seeing a notable increase.
  • The favorable market sentiment surrounding UNH can be linked to its surpassing of Wall Street's second-quarter outlooks and reaffirmation of its full-year profit guidance.
  • Despite obstacles such as the slow recovery from a cyberattack on Change Healthcare, investors were pleased with the company's strong financial results and resilience.
  • The overall bullish market uptrend, driven by firms like UnitedHealth, Boeing, and Caterpillar, contributed to the positive momentum in the stock market today.

17.06.2024 - UNH Stock was up 5.1%

  • Forecasts were raised by analysts after the company delivered better-than-expected second-quarter results.
  • Following the earnings report, UnitedHealth's stock price surged over 6%, making it the top gainer in the Dow.
  • UnitedHealth stock was upgraded to 'Buy' by Jefferies, underscoring strong growth potential for 2025.
  • Investor confidence was likely boosted by the positive earnings report and optimistic analyst outlook, driving the bullish movement in UNH stock.

17.06.2024 - UNH Stock was up 6.1%

  • UNH shares rose over 6% after a robust revenue growth report for Q2 2024, despite challenges from a recent cyber-attack.
  • Analysts at Jefferies upgraded UNH to a 'Buy' rating, foreseeing strong growth potential by 2025.
  • The optimistic analyst outlook and positive earnings performance likely drove the bullish trend in UNH stock.
  • Investor interest is high post-earnings surge, reflecting growing confidence in the company's performance and future outlook.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.